STING agonists drive intrinsic type I interferon responses in monocytes for optimal anti-tumor immunity

被引:0
|
作者
Yu, Tianning
Girard, Melanie
Watts, Tania H.
机构
关键词
D O I
10.1158/2326-6074.TUMIMM23-A012
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A012
引用
收藏
页数:2
相关论文
共 50 条
  • [41] The Optimal Radiation Dose to Induce Robust Systemic Anti-Tumor Immunity
    Poleszczuk, Jan
    Enderling, Heiko
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (11)
  • [42] THE MODULATING EFFECT OF INTERFERON PREPARATIONS ON CELLULAR REACTIONS INVOLVED IN ANTI-TUMOR IMMUNITY
    MKRTCHYAN, LN
    TERPOGOSYAN, ZR
    SARKISYAN, OM
    GEVORKYAN, RA
    MOVSESYAN, EA
    KAMALYAN, LA
    VOPROSY ONKOLOGII, 1983, 29 (08) : 7 - 11
  • [43] The tumor-intrinsic RNA binding protein HuR is essential for anti-tumor immunity in PDAC
    Guo, Yifei
    Finan, Jennifer M.
    Hedberg, Madeline D.
    Brody, Jonathan R.
    Eil, Robert
    CANCER RESEARCH, 2024, 84 (02)
  • [44] The tumor-intrinsic RNA binding protein HuR is essential for anti-tumor immunity in PDAC
    Guo, Yifei
    Finan, Jennifer M.
    Bartlett, Alexandra Q.
    Brody, Jonathan R.
    Eil, Robert
    CANCER RESEARCH, 2024, 84 (06)
  • [45] Role of heat as a regulator of innate immune responses and anti-tumor immunity
    Ostberg, JR
    Pritchard, MT
    Ertel, BR
    Dayanc, BE
    Patel, R
    Repasky, EA
    FASEB JOURNAL, 2003, 17 (07): : C73 - C73
  • [46] Ablation of the endoplasmic reticulum stress kinase PERK induces paraptosis and type I interferon to promote anti-tumor T cell responses
    Mandula, Jessica K.
    Chang, Shiun
    Mohamed, Eslam
    Jimenez, Rachel
    Sierra-Mondragon, Rosa A.
    Chang, Darwin C.
    Obermayer, Alyssa N.
    Moran-Segura, Carlos M.
    Das, Satyajit
    Vazquez-Martinez, Julio A.
    Prieto, Karol
    Chen, Ann
    Smalley, Keiran S. M.
    Czerniecki, Brian
    Forsyth, Peter
    Koya, Richard C.
    Ruffell, Brian
    Cubillos- Ruiz, Juan R.
    Munn, David H.
    Shaw, Timothy I.
    Conejo-Garcia, Jose R.
    Rodriguez, Paulo C.
    CANCER CELL, 2022, 40 (10) : 1145 - +
  • [47] Type 1 interferon mediated signaling is indispensable for eliciting anti-tumor responses by Mycobacterium indicus pranii
    Roy, Gargi
    Chakraborty, Anush
    Swami, Bharati
    Pal, Lalit
    Ahuja, Charvi
    Basak, Soumen
    Bhaskar, Sangeeta
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [48] A Biodegradable Antigen Nanocapsule Promotes Anti-Tumor Immunity via the cGAS-STING Pathway
    Jia, Xiangqian
    Chen, Hang
    Wu, Mengling
    Wang, Luyao
    Li, Tiantian
    Ma, Jing
    Yi, Xueqing
    Tan, Pengcheng
    Zheng, Peiyuan
    Du, Juanjuan
    ADVANCED FUNCTIONAL MATERIALS, 2023, 33 (10)
  • [49] Reovirus combined with a STING agonist enhances anti-tumor immunity in a mouse model of colorectal cancer
    Sugimura, Naomi
    Kubota, Eiji
    Mori, Yoshinori
    Aoyama, Mineyoshi
    Tanaka, Mamoru
    Shimura, Takaya
    Tanida, Satoshi
    Johnston, Randal N. N.
    Kataoka, Hiromi
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (11) : 3593 - 3608
  • [50] Reovirus combined with a STING agonist enhances anti-tumor immunity in a mouse model of colorectal cancer
    Naomi Sugimura
    Eiji Kubota
    Yoshinori Mori
    Mineyoshi Aoyama
    Mamoru Tanaka
    Takaya Shimura
    Satoshi Tanida
    Randal N. Johnston
    Hiromi Kataoka
    Cancer Immunology, Immunotherapy, 2023, 72 : 3593 - 3608